" Avicanna (TSX:AVCN) files US patent application for cannabinoid formulation
Avicanna (AVCN) has filed a provisional patent application with the United States Patent and Trademark Office.
" Algernon Pharmaceuticals (CSE:AGN) welcomes Dr. Mark Williams to the board
Algernon Pharmaceuticals (AGN) is pleased to announce that Dr. Mark Williams has been appointed as a member of the Board of Directors.
" Hemostemix (TSXV:HEM) closes the first tranche of its private placement
Hemostemix (HEM) has closed the first tranche of its non-brokered private placement for gross proceeds of $373,500.
" Clearmind Medicine (CSE:CMND) partners with The Hebrew University
Clearmind Medicine (CMND) has established a research and development partnership with the Yissum Research Development Company.
" Aurora Spine Corporation (TSXV:ASG) closes C$6.5M private placement
Aurora Spine Corporation (ASG) has closed its previously announced private placement for gross proceeds of $6,508,139.40.
" Cloud DX (TSXV:CDX) announces $3M brokered private placement of convertible debenture units
Cloud DX (CDX) has announced a brokered private placement of up to 3,000 convertible debenture units for gross proceeds of up to $3,000,000.